Cost of universal influenza vaccination of children in pediatric practices

Byung-Kwang Yoo1, Peter G Szilagyi, Stanley J Schaffer

  • 1University of Rochester, School of Medicine and Dentistry, Division of Health Policy and Outcomes Research, Department of Community and Preventive Medicine, 601 Elmwood Ave, Box 644, Rochester, NY 14642, USA. byung-kwang_yoo@urmc.rochester.edu

Pediatrics
|December 2, 2009
PubMed

Insights

Pediatric practices incur high costs for influenza vaccinations, exceeding reimbursement rates. Smaller and urban practices face greater financial burdens, impacting vaccine accessibility for children.

Area of Science:

  • Pediatric healthcare economics
  • Vaccination program costs
  • Public health policy

Background:

  • Influenza vaccination is crucial for child health.
  • Understanding pediatric practice costs is vital for effective vaccination programs.
  • Previous estimates of vaccination costs in pediatric settings are limited.

Purpose of the Study:

  • To estimate the national costs for pediatric practices to provide influenza vaccinations.
  • To simulate the financial impact of universal influenza vaccination for children.
  • To analyze cost variations based on practice size and location.

Main Methods:

  • Survey of 91 pediatric practices in New York State.
  • Data collection on resources for influenza vaccination.
  • Cost estimation adjusted for national pediatric practice data (2006 dollars).

Main Results:

  • Median total cost per vaccination was $28.62.
  • Labor and overhead costs constituted the majority of expenses.
  • Smaller and urban practices reported higher vaccination costs.

Conclusions:

  • Pediatric influenza vaccination costs are substantial and variable.
  • Costs often exceed reimbursement from programs like Vaccines for Children (VFC).
  • Financial losses may occur, potentially affecting vaccine delivery.
Abstract

Related Concept Videos

Vaccinations01:51

Vaccinations

Overview
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Influenza01:27

Influenza

Influenza is an acute, highly communicable viral disease that affects the respiratory tract and is responsible for seasonal epidemics worldwide. Influenza A is the most prevalent type associated with widespread outbreaks and is subtyped based on two surface glycoproteins: hemagglutinin (H) and neuraminidase (N), as in H1N1. These glycoproteins are essential for viral infectivity, transmission, and immune recognition. Transmission occurs primarily through respiratory droplets and contaminated...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Respiratory Syncytial Virus Disease01:29

Respiratory Syncytial Virus Disease

Human respiratory syncytial virus (RSV) is a widespread pathogen that primarily targets infants and young children but also poses a serious health risk to elderly and immunocompromised individuals. Belonging to the Pneumoviridae family, RSV is a negative-sense, single-stranded RNA virus within the Pneumovirus genus. Its global health burden is significant, with millions of cases annually resulting in hospitalizations and mortality, particularly in resource-limited settings. Although most...